Botanix Pharmaceuticals
  • Home
  • About Us
  • Products & Pipeline
  • Investors
  • News
  • Contact
  • Search
  • Menu Menu
  • Facebook
  • LinkedIn
  • Twitter
  • Youtube
News

Botanix Pharmaceuticals (ASX:BOT) launches Phase 2 BTX 1801 study for SSIs

March 13, 2020/in Latest News /by administrator
Source:
The Market Herald
https://themarketherald.com.au/botanix-pharmaceuticals-asxbot-launches-phase-2-btx-1801-study-for-ssis-2020-03-13

/wp-content/uploads/botanix-logo.png 0 0 administrator /wp-content/uploads/botanix-logo.png administrator2020-03-13 10:18:082023-03-13 21:17:21Botanix Pharmaceuticals (ASX:BOT) launches Phase 2 BTX 1801 study for SSIs

Categories

  • ASX Releases
  • Featured
  • Journal Articles
  • Latest News
  • News
  • Presentations
  • Videos

Contact Us

Privacy Policy

Your Privacy Rights

Consumer Health Data Privacy Policy

© 2025 Botanix SB Inc. All rights reserved. BOT-BOT-US-0001 06/2024
  • Terms of Use
Botanix Pharmaceuticals plans new study into antimicrobial platform and BTX... Botanix reshuffles business priorities
Scroll to top